Mirae Asset Global ETFs Holdings
ESPR icon

Mirae Asset Global ETFs Holdings’s Esperion Therapeutics ESPR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$308K Buy
112,469
+3,842
+4% +$12.2K ﹤0.01% 2131
2025
Q4 		$402K Buy
108,627
+14,854
+16% +$48K ﹤0.01% 1991
2025
Q3 		$248K Sell
93,773
-13,774
-13% -$26.6K ﹤0.01% 2212
2025
Q2 		$106K Sell
107,547
-4,802
-4% -$4.81K ﹤0.01% 2588
2025
Q1 		$162K Buy
112,349
+4,815
+4% +$8.87K ﹤0.01% 2420
2024
Q4 		$237K Buy
107,534
+3,279
+3% +$7.65K ﹤0.01% 2302
2024
Q3 		$172K Buy
+104,255
New +$211K ﹤0.01% 2436

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return